Last reviewed · How we verify
Post-exposure prophylaxis of influenza
Approved treatments
- Xofluza · Genentech Inc
Xofluza works by inhibiting the endonuclease activity of the influenza virus, preventing it from replicating. - Xofluza · Genentech Inc
Xofluza works by inhibiting the endonuclease activity of the influenza virus, preventing it from replicating.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Post-exposure prophylaxis of influenza patent landscape — cliff calendar, originator estates, attackable patents
- Post-exposure prophylaxis of influenza treatment landscape brief
- Post-exposure prophylaxis of influenza treatment updates RSS
Frequently asked questions about Post-exposure prophylaxis of influenza
What drugs treat Post-exposure prophylaxis of influenza?
Tracked treatments include Xofluza.
What is the treatment for Post-exposure prophylaxis of influenza?
Standard treatment for Post-exposure prophylaxis of influenza includes Xofluza. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Post-exposure prophylaxis of influenza patent cliff · Post-exposure prophylaxis of influenza CI report
- Treatment: Xofluza · Genentech Inc
- Treatment: Xofluza · Genentech Inc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing